Deciphering a hydrogen sulfide-related signature to supervise prognosis and therapeutic response in colon adenocarcinoma

被引:0
|
作者
Chen, Jinbiao [1 ]
Zhang, Yingchun [1 ]
机构
[1] Zhejiang Univ, Hangzhou Xixi Hosp, Med Coll, Dept Oncol, Hangzhou 310023, Zhejiang, Peoples R China
关键词
colon adenocarcinoma; hydrogen sulfide; immunotherapy; nomogram; prognosis; CLASS DISCOVERY; CANCER; RESISTANCE;
D O I
10.1097/MD.0000000000040031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hydrogen sulfide (H2S) is a critical molecule that participates in various molecular, physiological, and pathophysiological processes in biological systems. Emerging evidence has revealed that H2S is implicated in the progression of colon cancer and immune escape. Against this backdrop, the present study aimed to construct a prognostic risk feature for colon adenocarcinoma (COAD) by leveraging hydrogen sulfide-related genes (HSRG). Transcriptomic data and corresponding clinical-pathological information of colon cancer were obtained from The Cancer Genome Atlas and gene expression omnibus databases. Univariate Cox regression analysis was employed to assess the prognostic relevance of HSRG. Consensus clustering was utilized to perform molecular subtyping of COAD, followed by comparison of immune cell infiltration, drug sensitivity, and immune therapy response between subtypes. Differential expression gene and gene set enrichment analyses were conducted between subtypes. Univariate, lasso, and multivariate Cox regression analyses were applied to construct a prognostic model derived from HSRG. A nomogram model for predicting COAD prognosis was constructed and evaluated. In this study, we identified 12 HSRGs that were associated with COAD prognosis. Consensus clustering analysis revealed 3 COAD molecular subtypes that exhibited significant differences in terms of prognosis, tumor immune cell infiltration, drug sensitivity, and immune therapy response. Gene set enrichment analysis demonstrated that immunoregulatory processes were significantly suppressed in the poor-prognosis subtype while Wnt-related pathways and processes were significantly upregulated. Based on the differentially expressed genes between subtypes, we constructed a risk model comprising 11 genes that effectively distinguished high-risk patients from low-risk patients with significant associations with patient survival outcomes, drug treatment, pathological staging, and T staging. The HSRG-derived risk feature was an independent prognostic factor for COAD in drug treatment and pathological staging and could be integrated into a nomogram for prognosis prediction. Calibration curve, receiver operating characteristic curve, and decision curve analysis demonstrated excellent performance of the nomogram in evaluating COAD prognosis. Our study systematically assessed the prognostic significance of HSRG in COAD, identified HSRG-based molecular subtypes and risk features, and highlighted their potential utility in predicting prognosis and treatment response.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma
    Ma, Rong
    Zhao, Yanyun
    He, Miao
    Zhao, Hongliang
    Zhang, Yifan
    Zhou, Shuqi
    Gao, Mengcong
    Di, Di
    Wang, Jue
    Ding, Jian
    Wei, Minjie
    CANCER CELL INTERNATIONAL, 2019, 19 (01)
  • [42] An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
    Qi, Bing
    Liu, Han
    Zhou, Qi
    Ji, Li
    Shi, Xueying
    Wei, Yushan
    Gu, Yajun
    Mizushima, Akio
    Xia, Shilin
    AGING-US, 2021, 13 (14): : 18806 - 18826
  • [43] Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma
    Rong Ma
    Yanyun Zhao
    Miao He
    Hongliang Zhao
    Yifan Zhang
    Shuqi Zhou
    Mengcong Gao
    Di Di
    Jue Wang
    Jian Ding
    Minjie Wei
    Cancer Cell International, 19
  • [44] A novel liquid-liquid phase separation-related gene signature for predicting prognosis in colon cancer
    Wang, Shuo
    Hou, Sen
    Jiang, Shan
    Wang, Chao
    Zhang, Peipei
    Ye, Yingjiang
    Gao, Zhidong
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [45] Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma
    Liu, Jiahua
    Jiang, Chunhui
    Xu, Chunjie
    Wang, Dongyang
    Shen, Yuguang
    Liu, Ye
    Gu, Lei
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [46] Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma
    Jiahua Liu
    Chunhui Jiang
    Chunjie Xu
    Dongyang Wang
    Yuguang Shen
    Ye Liu
    Lei Gu
    Cancer Cell International, 21
  • [47] Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in colon adenocarcinoma
    Zheng, Lei
    Zhang, Jiale
    Ye, Yingquan
    Shi, Zhangpeng
    Huang, Yi
    Zhang, Mengmeng
    Gui, Zhongxuan
    Li, Ping
    Qin, Huanlong
    Sun, Weijie
    Zhang, Mei
    AGING-US, 2023, 15 (18): : 9521 - 9543
  • [48] Identification of a glycolysis-related and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma
    Liu, Cong
    Liu, Dingwei
    Xie, Yong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 73 - 73
  • [49] A novel anoikis-related gene signature to predict the prognosis, immune infiltration, and therapeutic outcome of lung adenocarcinoma
    Wang, Yanyan
    Xie, Chengkai
    Su, Yuan
    JOURNAL OF THORACIC DISEASE, 2023, 15 (03) : 1335 - 1352
  • [50] Identification of a glycolysis-related and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma
    Liu, Cong
    Liu, Dingwei
    Xie, Yong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 73 - 73